Clinical Trial

Hematopoietic Stem Cell-containing Autologous Blood Reinfusion for Bone Marrow Protection in Cervical Cancer Patients

Recruiting
View on ClinicalTrials.gov →
Summary
The aim of this project is to promote the reconstruction of haematopoietic function after chemoradiotherapy for cervical cancer with the innovative use of autologous haematopoietic containing stem cell blood transfusion support.To explore the effect of stored hemopoietic stem cell support therapy on bone marrow protection after concurrent chemoradiotherapy, in order to promote its clinical application.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2022-05-29; most recent amendment 2026-06-24.
Trial Details
NCT Number NCT05401175
Lead Sponsor Chongqing University Cancer Hospital
Conditions Cervical Cancer
Enrollment 40 participants
Start Date 2022-04-13
Primary Completion 2027-04 (estimated)
Study Completion 2029-04 (estimated)
Updated on ClinicalTrials.gov 2026-06-29